デジタルパソロジーの市場規模、シェア、動向分析レポート：製品別、タイプ別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

デジタルパソロジー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のデジタルパソロジーの市場規模は2030年までに17億4,000万米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR8.2％で成長すると予測されています。同市場は、正確な診断に対する需要の高まりに助けられた慢性疾患の有病率の上昇により、飛躍的な成長が見込まれています。慢性疾患は成人のほぼ3人に1人が罹患しています。CDCによると、米国では成人の約51.8％が少なくとも1つの慢性疾患を抱えています。分子組織プロファイリング、バイオバンク、組織マイクロアレイ解析、分子生物学を含むデジタルパソロジーは、医薬品開発パイプラインやコンパニオン診断において重要な役割を果たしています。組織ベースのバイオマーカー研究における高品質な組織サンプルの需要の高まりが、予測期間中の技術採用を促進すると予想されます。

2022年6月にTribun Healthが患者に臨床的かつタイムリーな専門知識を提供するために使用されるオンライン遠隔病理学プラットフォームであるTeleSlide Patho 5を発売するなど、技術の新バージョンの発売により遠隔病理学の採用が増加しています。さらに、各社が競争により厳しい戦略を採用するため、市場は近い将来、激しい競争に見舞われると予想されます。さらに、病理検査室のデジタル化などの技術進歩は、専門分野をより効率的にし、検体の再現性を高め、病理医の作業を容易にします。ここ数年、いくつかの画期的な進歩が市場の成長を大きく後押ししています。

例えば、2021年9月、Paigeは前立腺がん検出用AIソリューション「ペイジ・プロステート」のFDA承認を取得しました。同製品は、販売承認を取得した最初のAI対応病理製品です。これに続き、2021年10月にはF. Hoffmann-La Roche Ltd.とIbexが、患者ケアの向上を目的とした人工知能ベースの病理学用途の開発で提携しました。さらに、主要企業は、デジタルパソロジーの採用を強化するために、ロボット光顕微鏡、デジタル画像処理、複数の光ファイバー通信、コンピュータ化などの技術的進歩に焦点を当てた協働やパートナーシップのような戦略を採用しています。

例えば、2022年12月、Deciphexは、研究病理医が利用できるツールに革命を起こすことを目的とし、ユーザーが関連データとサンプルを効果的に管理できるLIMSソフトウェアの限界を克服するように設計されたデジタル研究病理学プラットフォーム、Patholytix 3.0を発売しました。さらに同社は、ワークフローに影響を与え、よりシンプルで迅速なレポート作成を可能にする新プラットフォームの特徴も発表しました。

デジタルパソロジー市場レポートハイライト

• 製品別では、デバイスセグメントが2024年に51.50%の最大シェアを占め、予測期間中に有利な成長率で成長すると予測されています。デバイスセグメントには、スライド管理システムとスキャナが含まれます。同分野の成長は、解像度を高めた学術研究活動におけるデジタルパソロジーの採用増加によるものです。
• 用途別では、疾病診断が、慢性疾患の蔓延と高貴な診断技術への需要の増加により、2025年から2030年にかけて最も速い成長率を示すと予測されています。
• 最終用途別では、病院分野が2024年に36.7％のシェアで市場を独占しました。これは、効率的な疾患診断のためにヘルスケア環境でのデジタルパソロジー診断の導入が拡大しているためです。
• 北米は、確立されたデジタルインフラの存在と、ヘルスケア環境への技術導入に関するいくつかの技術的進歩により、2024年には40.10%のシェアで市場全体を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 デジタルパソロジー市場の変数、動向、範囲

• デジタルパソロジー市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界の課題
  • 機会分析
• デジタルパソロジー市場分析ツール：ポーターのファイブフォース分析
• SWOT分析：要因別（政治・法律、経済、社会、技術）
  • テクノロジー動向分析
• 規制の枠組み
  • 新規プレイヤーに対する規制要件
  • 政治情勢、現状と将来のシナリオ
• コスト構造分析
  • 実装コスト
  • 価格低下分析
• ユーザーの視点分析
  • 消費者行動分析
• ケーススタディ
• COVID-19の影響
  • 市場参入戦略

第4章 デジタルパソロジー市場：製品推定・動向分析

• デジタルパソロジー市場：製品の主なポイント
• デジタルパソロジー市場：製品変動分析
• ソフトウェア
• デバイス
  • スキャナー
  • スライド管理システム
• ストレージシステム

第5章 デジタルパソロジー市場：用途推定・動向分析

• デジタルパソロジー市場：用途の主なポイント
• デジタルパソロジー市場：用途変動分析
• 創薬・医薬品開発
• 学術研究
• 病気の診断
  • がん細胞の検出
  • その他

第6章 デジタルパソロジー市場：タイプ推定・動向分析

• デジタルパソロジー市場：タイプの主なポイント
• デジタルパソロジー市場：タイプ変動分析
• 人間の病理学
• 獣医の病理学

第7章 デジタルパソロジー市場：最終用途推定・動向分析

• デジタルパソロジー市場：最終用途の主要ポイント
• デジタルパソロジー市場：最終用途変動分析
• 病院
• バイオテクノロジー・製薬会社
• 診断検査室
• 学術・研究機関

第8章 デジタルパソロジー市場：地域推定・動向分析（製品、用途、最終用途別）

• デジタルパソロジー市場：地域変動分析
• デジタルパソロジー市場シェア（地域別）、2023年・2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ロシア
  • オランダ
  • スイス
  • スウェーデン
  • デンマーク
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • インドネシア
  • タイ
  • オーストラリア
  • 韓国
  • フィリピン
  • マレーシア
  • シンガポール
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • トルコ
  • イラン
  • アラブ首長国連邦
  • イスラエル
  • クウェート

第9章 デジタルパソロジー市場の競争とベンダー情勢

• 参加カテゴリー
• ベンダー情勢
  • 販売代理店リスト
• 企業の市況分析
  • 公開会社
  • 非公開会社
• 2024年の企業市場シェア推定分析（％）
• 企業プロファイル
  • Leica Biosystems Nussloch Gmbh (Danaher)
  • HAMAMATSU PHOTONICS K.K.
  • KONINKLIJKE PHILIPS N.V.
  • OLYMPUS CORPORATION
  • MIKROSCAN TECHNOLOGIES, INC.
  • INSPIRATA, INC.
  • VISIOPHARM A/S
  • HURON TECHNOLOGIES INTERNATIONAL, INC.
  • 3DHISTECH LTD.
  • CONTEXTVISION AB
  • SECTRA AB
  • AGFA-GEVAERT GROUP
  • CELLAVISIONン
  • HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
  • WEST MEDICA PRODUKTIONS- UND HANDELS- GMBH (WEST MEDICA)
  • AETHERAI
  • IBEX (IBEX MEDICAL ANALYTICS)
  • SIGTUPLE TECHNOLOGIES PRIVATE LIMITED
  • MORPHLE LABS, INC
  • BIONOVATION BIOTECH, INC
  • SCOPIO LABS
  • PATH HUB US
  • F. HOFFMANN-LA ROCHE LTD.
  • Aiosyn
  • Proscia Inc
  • EVIDENT
  • Aignostics, Inc.
  • AIRA MATRIX
  • Deep Bio Inc.
  • Indica Labs, LLC
  • Paige AI
  • PathAI, Inc.
  • Aiforia
  • Dedalus S.p.A
  • Qritive
  • Mindpeak GmbH
  • CGI Inc.
  • Gestalt
  • Epredia (3DHISTECH Ltd.)

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 North America Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
• Table 4 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 5 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 6 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 7 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 8 U.S. Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 9 U.S. Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 10 U.S. Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 11 U.S. Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 12 Canada Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 13 Canada Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 14 Canada Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 15 Canada Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 16 Mexico Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 17 Mexico Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 18 Mexico Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 19 Mexico Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 20 Europe Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
• Table 21 Europe Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 22 Europe Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 23 Europe Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 24 Europe Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 25 UK Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 26 UK Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 27 UK Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 28 UK Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 29 Germany Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 30 Germany Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 31 Germany Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 32 Germany Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 33 France Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 34 France Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 35 France Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 36 France Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 37 Italy Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 38 Italy Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 39 Italy Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 40 Italy Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 41 Spain Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 42 Spain Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 43 Spain Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 44 Spain Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 45 Russia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 46 Russia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 47 Russia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 48 Russia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 49 Switzerland Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 50 Switzerland Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 51 Switzerland Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 52 Switzerland Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 53 Netherlands Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 54 Netherlands Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 55 Netherlands Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 56 Netherlands Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 57 Denmark Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 58 Denmark Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 59 Denmark Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 60 Denmark Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 61 Norway Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 62 Norway Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 63 Norway Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 64 Norway Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 65 Sweden Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 66 Sweden Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 67 Sweden Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 68 Sweden Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 69 Asia Pacific Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
• Table 70 Asia Pacific Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 71 Asia Pacific Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 72 Asia Pacific Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 73 Asia Pacific Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 74 Japan Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 75 Japan Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 76 Japan Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 77 Japan Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 78 China Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 79 China Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 80 China Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 81 China Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 82 India Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 83 India Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 84 India Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 85 India Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 86 Indonesia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 87 Indonesia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 88 Indonesia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 89 Indonesia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 90 Thailand Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 91 Thailand Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 92 Thailand Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 93 Thailand Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 94 Australia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 95 Australia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 96 Australia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 97 Australia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 98 South Korea Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 99 South Korea Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 100 South Korea Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 101 South Korea Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 102 Philippines Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 103 Philippines Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 104 Philippines Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 105 Philippines Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 106 Malaysia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 107 Malaysia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 108 Malaysia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 109 Malaysia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 110 Singapore Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 111 Singapore Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 112 Singapore Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 113 Singapore Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 114 Latin America Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 115 Latin America Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 116 Latin America Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 117 Latin America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 118 Brazil Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 119 Brazil Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 120 Brazil Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 121 Brazil Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 122 Argentina Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 123 Argentina Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 124 Argentina Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 125 Argentina Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 126 MEA Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 127 MEA Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 128 MEA Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 129 MEA Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 130 South Africa Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 131 South Africa Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 132 South Africa Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 133 South Africa Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 134 Saudi Arabia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 135 Saudi Arabia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 136 Saudi Arabia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 137 Saudi Arabia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 138 Turkey Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 139 Turkey Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 140 Turkey Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 141 Turkey Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 142 Iran Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 143 Iran Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 144 Iran Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 145 Iran Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 146 UAE Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 147 UAE Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 148 UAE Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 149 UAE Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 150 Israel Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 151 Israel Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 152 Israel Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 153 Israel Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
• Table 154 Kuwait Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
• Table 155 Kuwait Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
• Table 156 Kuwait Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
• Table 157 Kuwait Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Digital pathology market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2024)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Digital pathology market: Product movement analysis
• Fig. 17 Digital pathology market: Product segment dashboard
• Fig. 18 Digital pathology market product outlook: Key takeaways
• Fig. 19 Software market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 20 Integrated Software market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 21 Standalone Software market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 22 Device market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 23 Storage system market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 24 Digital pathology market: Type movement analysis
• Fig. 25 Digital pathology market: Type segment dashboard
• Fig. 26 Digital pathology market type outlook: Key takeaways
• Fig. 27 Human digital pathology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 28 Veterinary digital pathology market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 29 Digital pathology market: Application movement analysis
• Fig. 30 Digital pathology market: Application segment dashboard
• Fig. 31 Digital pathology market application outlook: Key takeaways
• Fig. 32 Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 33 Academic research market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 34 Disease diagnosis market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 35 Digital pathology market: End-use movement analysis
• Fig. 36 Digital pathology market: End-use segment dashboard
• Fig. 37 Digital pathology market end-use outlook: Key takeaways
• Fig. 38 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 39 Biotech & pharma companies market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 40 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 41 Academic &research institutes market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 42 Regional outlook, 2023 & 2030
• Fig. 43 Regional market dashboard
• Fig. 44 Regional market place: Key takeaways
• Fig. 45 North America, SWOT
• Fig. 46 Europe, SWOT
• Fig. 47 Asia Pacific, SWOT
• Fig. 48 Latin America, SWOT
• Fig. 49 Middle East and Africa, SWOT
• Fig. 50 North America
• Fig. 51 North America Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 52 U.S. Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 53 Canada Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 54 Mexico Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 55 Europe Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 56 UK Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 57 Germany Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 58 Spain Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 59 France Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 60 Italy Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 61 Russia Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 62 Ntherlands Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 63 Switzerland Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 64 Denmark Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 65 Norway Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 66 Sweden Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 67 Asia Pacific Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 68 Japan Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 69 China Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 70 India Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 71 South Korea Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 72 Australia Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 73 Thailand Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 74 Indonasia Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 75 South Korea Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 76 Philippines Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 77 Malaysia Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 78 Singapore Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 79 Latin America Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 80 Brazil Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 81 Argentina Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 82 MEA Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 83 South Africa Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 84 Saudi Arabia Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 85 Turkey Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 86 Iran Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 87 Italy Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 88 UAE Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 89 Isarel Digital pathology market, 2018 - 2030 (USD Billion)
• Fig. 90 Kuwait Digital pathology market, 2018 - 2030 (USD Billion)

Digital Pathology Market Growth & Trends:

The global digital pathology market size is anticipated to reach USD 1.74 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.2% from 2025 to 2030. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period.

Increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete. Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In past few years, several breakthrough advancements have provided a significant boost to market growth.

For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care. Furthermore, major players are adopting strategies like collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiber optic communications, and computerization, to enhance the adoption of digital pathology.

For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation.

Digital Pathology Market Report Highlights:

• Based on product, The device segment held the largest share of 51.50% in 2024 and is anticipated to grow at a lucrative growth rate during the projected period. The device segment includes a slide management system and scanner. The segment growth is attributed to the increasing adoption of digital pathology in academic research activities with enhanced resolution
• Based on application, Disease diagnosis is anticipated to witness the fastest growth rate from 2025 to 2030 due to an increasing prevalence of chronic diseases and demand for noble diagnosis techniques
• In terms of end-use, The hospitals segment dominated the market in 2024 with a share of 36.7% due to the growing incorporation of digital pathologies in healthcare settings for efficient disease diagnosis
• North America dominated overall market in 2024 with a share of 40.10%, due to the presence of well-established digital infrastructure and several technological advancements pertaining to the incorporation of technology in healthcare settings

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
• 1.4 Model Details
  • 1.4.1 Commodity Workflow Analysis (Model 1)
  • 1.4.2 Volume Price Analysis (Model 2)
  • 1.4.3 Market Survey Research Methodology
    • 1.4.3.1 General Methodology
  • 1.4.4 Country Level Assumptions
  • 1.4.5 Subsegment Level Assumptions
• 1.5 List of Primary Sources
• 1.6 List of Secondary Sources
• 1.7 List of Abbreviations
• 1.8 Market Definitions
• 1.9 Report Objectives

Chapter 2 Executive Summary

• 2.1 Digital Pathology Market Snapshot
  • 2.1.1 Digital Pathology Market Snapshot: Type & Product Segment Outlook
  • 2.1.2 Digital Pathology Market Snapshot: Application & End Use Segment Outlook
  • 2.1.3 Digital Pathology Market Snapshot: Competitive Outlook

Chapter 3 Digital Pathology Market Variables, Trends and Scope

• 3.1 Digital Pathology Market Dynamics
  • 3.1.1 Market Driver Analysis
    • 3.1.1.1 Increasing prevalence of chronic diseases
    • 3.1.1.2 Higher cost-efficiency
    • 3.1.1.3 Rapid technological advancements in the overall digital pathology market
      • 3.1.1.3.1 Competitive Factors and Strategies
        • 3.1.1.3.1.1 List of Top Notable Funded Digital Pathology Companies, By Countries
        • 3.1.1.3.1.2 Top 10 Vendor - by Total Funding from 2014 - 2021 (Potential vendors for collabrations)
    • 3.1.1.4 Increasing demand for integrated healthcare systems and patient-centric care-
    • 3.1.1.5 Growing adoption of digital pathology solutions in veterinary care practices
    • 3.1.1.6 Rapid technological advancements in digital pathology solutions in veterinary field
  • 3.1.2 Market Restraint Analysis
    • 3.1.2.1 Lack of skilled professionals
    • 3.1.2.2 High cost of implementing digital pathology solutions
      • 3.1.2.2.1 Digital Pathology Expenses
  • 3.1.3 Industry Challenges
    • 3.1.3.1 Lack of reimbursement for digital pathology-enabled services
    • 3.1.3.2 Data security and privacy
  • 3.1.4 Opportunity Analysis
    • 3.1.4.1 Potential growth for digital pathology solutions
• 3.2 Digital Pathology Market Analysis Tools: Porters
• 3.3 SWOT Analysis by Factors (Political & Legal, Economic, Social, and Technology)
  • 3.3.1 Technology Trend Analysis
    • 3.3.1.1 Digitization in Pathology Labs
• 3.4 Regulatory Framework
  • 3.4.1 Regulatory Requirements For New Players
    • 3.4.1.1 Food and Drug Administration (FDA)
    • 3.4.1.2 Centers for Medicare and Medicaid Services (CMS)/Clinical Laboratory Improvement Amendments (CLIA)
    • 3.4.1.3 College of American Pathologists (CAP)
  • 3.4.2 Political Landscape, Current & Future Scenario
• 3.5 Cost Structure Analysis
  • 3.5.1 Cost Of Implementation
    • 3.5.1.1 Secondary Research Analysis on digital pathology operational costs
  • 3.5.2 Price Erosion Analysis
• 3.6 User Perspective Analysis
  • 3.6.1 Consumer Behaviour Analysis
    • 3.6.1.1 Consumer Preference
• 3.7 Case Study
• 3.8 Covid-19 Impact
  • 3.8.1 Market Entry Strategies
    • 3.8.1.1 Competitive Strategies

Chapter 4 Digital Pathology Market: Product Estimates & Trend Analysis

• 4.1 Digital Pathology Market: Product Key Takeaways
• 4.2 Digital Pathology Market: Product Movement Analysis
• 4.3 Software
  • 4.3.1 Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 4.4 Device
  • 4.4.1 Device Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.4.2 Scanners
    • 4.4.2.1 Scanners Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.4.3 Slide Management System
    • 4.4.3.1 Slide Management System Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 4.5 Storage System
  • 4.5.1 Storage System Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5 Digital Pathology Market: Application Estimates & Trend Analysis

• 5.1 Digital Pathology Market: Application Key Takeaways
• 5.2 Digital Pathology Market: Application Movement Analysis
• 5.3 Drug Discovery & Development
  • 5.3.1 Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 5.4 Academic Research
  • 5.4.1 Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 5.5 Disease Diagnosis
  • 5.5.1 Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.2 Cancer Cell Detection
    • 5.5.2.1 Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.3 Others
    • 5.5.3.1 Others market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6 Digital Pathology Market: Type Estimates & Trend Analysis

• 6.1 Digital Pathology Market: Type Key Takeaways
• 6.2 Digital Pathology Market: Type Movement Analysis
• 6.3 Human Pathology
  • 6.3.1 Human Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 6.4 Veterinary Pathology
  • 6.4.1 Veterinary Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7 Digital Pathology Market: End-use Estimates & Trend Analysis

• 7.1 Digital Pathology Market: End-Use Key Takeaways
• 7.2 Digital Pathology Market: End-Use Movement Analysis
• 7.3 Hospitals
  • 7.3.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 7.4 Biotechnology & Pharmaceutical Companies
  • 7.4.1 Biotechnology & Pharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 7.5 Diagnostic Laboratories
  • 7.5.1 Diagnostic Laboratories Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 7.6 Academic And Research Institutes
  • 7.6.1 Academic And Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 8 Digital Pathology Market: Regional Estimates & Trend Analysis, by Product, Application, End Use

• 8.1 Digital Pathology Market: Region Movement Analysis
• 8.2 Digital Pathology Market Shares by Region, 2023 & 2030
• 8.3 North America
  • 8.3.1 North America Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 8.3.2 U.S.
    • 8.3.2.1 U.S. digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.3.3 Canada
    • 8.3.3.1 Canada digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.3.4 Mexico
    • 8.3.3.1 Canada digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
• 8.4 Europe
  • 8.4.1 Europe Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 8.4.3 UK
    • 8.4.3.1 UK digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.4 Germany
    • 8.4.4.1 Germany digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.5 France
    • 8.4.5.1 France digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.6 Italy
    • 8.4.6.1 Italy digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.7 Spain
    • 8.4.7.1 Spain digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.8 Russia
    • 8.4.8.1 Russia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.9 Netherlands
    • 8.4.9.1 Netherlands digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.10 Switzerland
    • 8.4.10.1 Switzerland digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.11 Sweden
    • 8.4.11.1 Sweden digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.12 Denmark
    • 8.4.12.1 Denmark digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4.13 Norway
    • 8.4.13.1 Norway digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
• 8.5 Asia Pacific
  • 8.5.1 Asia Pacific Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 8.5.2 Japan
    • 8.5.2.1 Japan digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.3 China
    • 8.5.3.1 China digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.4 India
    • 8.5.4.1 India digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.5 Indonesia
    • 8.5.5.1 Indonesia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.6 Thailand
    • 8.5.6.1 Thailand digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.7 Australia
    • 8.5.7.1 Australia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.8 South Korea
    • 8.5.8.1 South Korea digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.9 Philippines
    • 8.5.9.1 Philippines digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.11 Malaysia
    • 8.5.11.1 Malaysia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5.12 Singapore
    • 8.5.12.1 Singapore digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
• 8.6 Latin America
  • 8.6.1 Latin America Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 8.6.3 Brazil
    • 8.6.3.1 Brazil digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.6.4 Argentina
    • 8.6.4.1 Argentina digital pathology market estimates and forecasts, 2018- 2030 (USD Billion)
• 8.7 MEA
  • 8.7.1 Mea Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 8.7.2 South Africa
    • 8.7.2.1 South Africa digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.7.3 Saudi Arabia
    • 8.7.3.1 Saudi arabia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.7.4 Turkey
    • 8.7.4.1 Turkey digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.7.5 Iran
    • 8.7.5.1 Iran digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.7.6 UAE
    • 8.7.6.1 UAE digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.7.7 Israel
    • 8.7.7.1 Israel digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.7.8 Kuwait
    • 8.7.8.1 Kuwait digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 9 Digital Pathology Market Competitive & Vendor Landscape

• 9.1 Participation Categorization
• 9.2 Vendor Landscape
  • 9.2.1 List Of Distributors
• 9.3 Company Market Position Analysis
  • 9.3.1 Public Companies
  • 9.3.2 Private Companies
• 9.4 Estimated Company Market Share Analysis, 2024 (%)
• 9.5 Company Profiles
  • 9.5.1 Leica Biosystems Nussloch Gmbh (Danaher)
    • 9.5.1.1 Company overview
    • 9.5.1.2 Financial performance
    • 9.5.1.3 Product benchmarking
      • 9.5.1.3.1 Human DIgital Pathology
    • 9.5.1.4 Strategic initiatives
  • 9.5.2 HAMAMATSU PHOTONICS K.K.
    • 9.5.2.1 Company overview
    • 9.5.2.2 Financial performance
    • 9.5.2.3 Product benchmarking
      • 9.5.2.3.1 Human DIgital Pathology
    • 9.5.2.4 Strategic initiatives
  • 9.5.3 KONINKLIJKE PHILIPS N.V.
    • 9.5.3.1 Company overview
    • 9.5.3.2 Financial performance
    • 9.5.3.3 Product benchmarking
      • 9.5.3.3.1 Human DIgital Pathology
    • 9.5.3.4 Strategic initiatives
  • 9.5.4 OLYMPUS CORPORATION
    • 9.5.4.1 Company overview
    • 9.5.4.2 Financial performance
    • 9.5.4.3 Product benchmarking
      • 9.5.4.3.1 Human DIgital Pathology
    • 9.5.4.4 Strategic initiatives
    • 9.5.4.5 Company overview
    • 9.5.4.6 Financial performance
    • 9.5.4.7 Product benchmarking
      • 9.5.4.7.1 Human DIgital Pathology
    • 9.5.4.8 Strategic initiatives
  • 9.5.5 MIKROSCAN TECHNOLOGIES, INC.
    • 9.5.5.1 Company overview
    • 9.5.5.2 Financial performance
    • 9.5.5.3 Product benchmarking
      • 9.5.5.3.1 Human DIgital Pathology
    • 9.5.5.4 Strategic initiatives
  • 9.5.6 INSPIRATA, INC.
    • 9.5.6.1 Company overview
    • 9.5.6.2 Financial performance
    • 9.5.6.3 Product benchmarking
      • 9.5.6.3.1 Human DIgital Pathology
    • 9.5.6.4 Strategic initiatives
  • 9.5.7 VISIOPHARM A/S
    • 9.5.7.1 Company overview
    • 9.5.7.2 Financial performance
    • 9.5.7.3 Product benchmarking
      • 9.5.7.3.1 Human DIgital Pathology
    • 9.5.7.4 Strategic initiatives
  • 9.5.8 HURON TECHNOLOGIES INTERNATIONAL, INC.
    • 9.5.8.1 Company overview
    • 9.5.8.2 Financial performance
    • 9.5.8.3 Product benchmarking
      • 9.5.8.3.1 Human DIgital Pathology
    • 9.5.8.4 Strategic initiatives
  • 9.5.9 3DHISTECH LTD.
    • 9.5.9.1 Company overview
    • 9.5.9.2 Financial performance
    • 9.5.9.3 Product benchmarking
      • 9.5.9.3.1 Human DIgital Pathology
      • 9.5.9.3.2 Veterinary DIgital Pathology
    • 9.5.9.4 Strategic initiatives
  • 9.5.10 CONTEXTVISION AB
    • 9.5.10.1 Company overview
    • 9.5.10.2 Financial performance
    • 9.5.10.3 Product benchmarking
      • 9.5.10.3.1 Human DIgital Pathology
    • 9.5.10.4 Strategic initiatives
  • 9.5.11 SECTRA AB
    • 9.5.11.1 Company overview
    • 9.5.11.2 Financial Performance
    • 9.5.11.3 Product benchmarking
      • 9.5.11.3.1 Human DIgital Pathology
    • 9.5.11.4 Strategic initiatives
  • 9.5.12 AGFA-GEVAERT GROUP
    • 9.5.12.1 Company overview
    • 9.5.12.2 Financial Performance
    • 9.5.12.3 Product benchmarkin
      • 9.5.12.3.1 Human DIgital Pathology
    • 9.5.12.4 Strategic initiatives
  • 9.5.13 CELLAVISION
    • 9.5.13.1 Company overview
    • 9.5.13.2 Financial performance
    • 9.5.13.3 Product benchmarking
      • 9.5.13.3.1 Veterinary DIgital Pathology
    • 9.5.13.4 Strategic initiatives
  • 9.5.14 HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
    • 9.5.14.1 Company overview
    • 9.5.14.2 Financial performance
    • 9.5.14.3 Product benchmarking
      • 9.5.14.3.1 Human DIgital Pathology
  • 9.5.15 WEST MEDICA PRODUKTIONS- UND HANDELS- GMBH (WEST MEDICA)
    • 9.5.15.1 Company overview
    • 9.5.15.2 Financial performance
    • 9.5.15.3 Product benchmarking
      • 9.5.15.3.1 Human DIgital Pathology
      • 9.5.15.3.2 Veterinary DIgital Pathology
  • 9.5.16 AETHERAI
    • 9.5.16.1 Company overview
    • 9.5.16.2 Financial performance
    • 9.5.16.3 Product benchmarking
      • 9.5.16.3.1 Human DIgital Pathology
    • 9.5.16.4 Strategic initiatives
  • 9.5.17 IBEX (IBEX MEDICAL ANALYTICS)
    • 9.5.17.1 Company overview
    • 9.5.17.2 Financial performance
    • 9.5.17.3 Product benchmarking
      • 9.5.17.3.1 Human DIgital Pathology
    • 9.5.17.4 Strategic initiatives
  • 9.5.18 SIGTUPLE TECHNOLOGIES PRIVATE LIMITED
    • 9.5.18.1 Company overview
    • 9.5.18.2 Financial performance
    • 9.5.18.3 Product benchmarking
      • 9.5.18.3.1 Human DIgital Pathology
    • 9.5.18.4 Strategic initiatives
  • 9.5.19 MORPHLE LABS, INC
    • 9.5.19.1 Company overview
    • 9.5.19.2 Financial performance
    • 9.5.19.3 Product benchmarking
      • 9.5.19.3.1 Human DIgital Pathology
    • 9.5.19.4 Strategic initiatives
  • 9.5.20 BIONOVATION BIOTECH, INC
    • 9.5.20.1 Company overview
    • 9.5.20.2 Financial performance
    • 9.5.20.3 Product benchmarking
      • 9.5.20.3.1 Human DIgital Pathology
  • 9.5.21 SCOPIO LABS
    • 9.5.21.1 Company overview
    • 9.5.21.2 Financial performance
    • 9.5.21.3 Product benchmarking
      • 9.5.21.3.1 Veterinary DIgital Pathology
    • 9.5.21.4 Strategic initiatives
  • 9.5.22 PATH HUB US
    • 9.5.22.1 Company overview
    • 9.5.22.2 Product benchmarking
      • 9.5.22.2.1 Human Digital Pathology
      • 9.5.22.2.2 Veterinary Digital Pathology
  • 9.5.23. F. HOFFMANN-LA ROCHE LTD.
    • 9.5.23.1. Overview
    • 9.5.23.2. Financial Performance
    • 9.5.23.3. Product Benchmarking
    • 9.5.23.4. Strategic Initiatives
  • 9.5.24. Aiosyn
    • 9.5.24.1. Overview
    • 9.5.24.2. Financial Performance
    • 9.5.24.3. Product Benchmarking
    • 9.5.24.4. Strategic Initiatives
  • 9.5.25. Proscia Inc
    • 9.5.25.1. Overview
    • 9.5.25.2. Financial Performance
    • 9.5.25.3. Product Benchmarking
    • 9.5.25.4. Strategic Initiatives
  • 9.5.26. EVIDENT
    • 9.5.26.1. Overview
    • 9.5.26.2. Financial Performance
    • 9.5.26.3. Product Benchmarking
    • 9.5.26.4. Strategic Initiatives
  • 9.5.27. Aignostics, Inc.
    • 9.5.27.1. Overview
    • 9.5.27.2. Financial Performance
    • 9.5.27.3. Product Benchmarking
    • 9.5.27.4. Strategic Initiatives
  • 9.5.28. AIRA MATRIX
    • 9.5.28.1. Overview
    • 9.5.28.2. Financial Performance
    • 9.5.28.3. Product Benchmarking
    • 9.5.28.4. Strategic Initiatives
  • 9.5.29. Deep Bio Inc.
    • 9.5.29.1. Overview
    • 9.5.29.2. Financial Performance
    • 9.5.29.3. Product Benchmarking
    • 9.5.29.4. Strategic Initiatives
  • 9.5.30. Indica Labs, LLC
    • 9.5.30.1. Overview
    • 9.5.30.2. Financial Performance
    • 9.5.30.3. Product Benchmarking
    • 9.5.30.4. Strategic Initiatives
  • 9.5.31. Paige AI
    • 9.5.31.1. Overview
    • 9.5.31.2. Financial Performance
    • 9.5.31.3. Product Benchmarking
    • 9.5.31.4. Strategic Initiatives
  • 9.5.32. PathAI, Inc.
    • 9.5.32.1. Overview
    • 9.5.32.2. Financial Performance
    • 9.5.32.3. Product Benchmarking
    • 9.5.32.4. Strategic Initiatives
  • 9.5.33. Aiforia
    • 9.5.33.1. Overview
    • 9.5.33.2. Financial Performance
    • 9.5.33.3. Product Benchmarking
    • 9.5.33.4. Strategic Initiatives
  • 9.5.34. Dedalus S.p.A
    • 9.5.34.1. Overview
    • 9.5.34.2. Financial Performance
    • 9.5.34.3. Product Benchmarking
    • 9.5.34.4. Strategic Initiatives
  • 9.5.35. Qritive
    • 9.5.35.1. Overview
    • 9.5.35.2. Financial Performance
    • 9.5.35.3. Product Benchmarking
    • 9.5.35.4. Strategic Initiatives
  • 9.5.36. Mindpeak GmbH
    • 9.5.36.1. Overview
    • 9.5.36.2. Financial Performance
    • 9.5.36.3. Product Benchmarking
    • 9.5.36.4. Strategic Initiatives
  • 9.5.37. CGI Inc.
    • 9.5.37.1. Overview
    • 9.5.37.2. Financial Performance
    • 9.5.37.3. Product Benchmarking
    • 9.5.37.4. Strategic Initiatives
  • 9.5.38. Gestalt
    • 9.5.38.1. Overview
    • 9.5.38.2. Financial Performance
    • 9.5.38.3. Product Benchmarking
    • 9.5.38.4. Strategic Initiatives
  • 9.5.39 Epredia (3DHISTECH Ltd.)
    • 9.5.39.1. Overview
    • 9.5.39.2. Financial Performance
    • 9.5.39.3. Product Benchmarking
    • 9.5.39.4. Strategic Initiatives